ABSTRACr Eight patients with exercise-induced asthma participated in a single-blind trial comparing the protective effects of inhaled lignocaine (estimated dose 48 mg), sodium cromoglycate (estimated dose 12 mg), and ipratropium bromide (estimated dose 120 ,g). Saline was used as control. Effects were assessed from the mean maximal percentage fall in forced expiratory volume in one second (FEVI) ipratropium bromide were 38 1% (5-0), 34.5% (6-1), 11-3% (3-7), and 19-3% (7-4) respectively. Similarly, the mean maximal falls in MMFR after saline, lignocaine, sodium cromoglycate, and ipratropium bromide were 54 4% (5-2), 52 9% (7 7), 23-6% (6-6), and 32-1% (10(5) cholinergic receptors in the airways. In this study we have compared the effect of inhaled lignocaine, ipratropium bromide, and sodium cromoglycate in eight patients with extrinsic and reproducible exercise-induced asthma.
ipratropium bromide were 38 1% (5-0), 34.5% (6-1), 11-3% (3-7), and 19-3% (7-4) respectively. Similarly, the mean maximal falls in MMFR after saline, lignocaine, sodium cromoglycate, and ipratropium bromide were 54 4% (5-2), 52 9% (7 7), 23-6% , and 32-1% (10(5) respectively. The inhibitory effects of sodium cromoglycate and ipratropium bromide were significant whereas lignocaine failed to produce an effect. These results suggest that mediator release is an important factor in exercise-induced asthma and that in some patients the effects of the mediators may be on the postsynaptic muscarinic receptors. Local anaesthesia of sensory vagal receptors, on the other hand, does not prevent exercise asthma and these receptors do not appear to have any important role in exercise-induced bronchoconstriction.
The exact mechanism of exercise-induced asthma remains unclear; stimulation of a vagal reflex and the release of mast cell mediators in response to exercise have both been postulated.' 2 Recent studies have related exercise asthma to hyperventilation and subsequent airway heat loss but have failed to clarify whether the respiratory heat loss stimulates the irritant receptors in the airways or causes mast cell degranulation.3 Local anaesthesia of the upper airways with lignocaine has been shown to inhibit bronchoconstriction induced by inhalation of cold air and by exercise in patients with asthma.4 5 Sodium cromoglycate, which suppresses the release of mast cell mediators in vitro, is effective in preventing exercise-induced asthma.6 7 More recently sodium cromoglycate has been shown to attenuate bronchoconstriction induced by cold air, methacholine, and histamine in asthmatic patients.8-"' It has been proposed that this additional effect of sodium cromoglycate may be mediated either directly on the bronchial smooth muscle or through an action on the cholinergic receptors in the airways. In this study we have compared the effect of inhaled lignocaine, ipratropium bromide, and sodium cromoglycate in eight patients with extrinsic and reproducible exercise-induced asthma.
Patients and methods
Twelve patients with extrinsic and reproducible exercise-induced asthma were included in the trial. Four of these patients had to be excluded because they developed considerable and prolonged bronchoconstriction after inhalation of lignocaine (4 g/l). The remaining eight patients, aged 17-49 years (mean 312, SEM 4(0) were studied. Sodium cromoglycate and bronchodilator drugs were discontinued for 24 hours before each test was carried out (patients taking oral or aerosol corticosteroids or antihistamines had been excluded from the study). All the patients were non-smokers and gave informed consent to be studied. Forced Effect oflignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma Recent work has suggested that exercise-induced asthma is related to hyperventilation and subsequent airway heat loss, but it remains unclear whether this is due primarily to stimulation of irritant vagal receptors or to a direct effect on mast cell degranulation.' 2 While isocapnic hyperventilation does not cause a rise in blood histamine concentrations in asthmatic patients,'4 15 some workers have shown a rise in histamine after exercise, particularly in patients with asthma. 1517 The failure of local anaesthesia to modify bronchoconstriction induced by histamine and prostaglandin F2a'8 and also to prevent exerciseinduced asthma suggests that the mechanism of postexercise bronchoconstriction is probably different from that of bronchoconstriction produced by hyperventilation and airway cooling. The beneficial effects of ipratropium bromide and sodium cromoglycate observed in exercise-induced asthma support previous observations.' 2 19 The preventive effect of sodium cromoglycate was greater than that of ipratropium bromide, though the difference did not reach significance. The vagal mechanism apparently plays an important part only in patients whose main site of airflow obstruction is in the large airways.2 9 In contrast, sodium cromoglycate prevents exerciseinduced asthma irrespective of the site of airflow obstruction'9 and also attenuates the bronchoconstriction induced by cold air in asthmatic patients.8 Sodium cromoglycate, in addition to stabilising the mast cell membrane, may suppress the bronchial reactivity to the released mediators and this may explain why it is more effective in preventing exercise-induced asthma than is ipratropium bromide. The failure of local anaesthesia to prevent exercise-induced bronchoconstriction or to modify the effect of inhaled histamine and prostaglandin F2o, 18 suggests that the sensory irritant receptors in the airway do not have a significant role in exerciseinduced or chemically induced bronchoconstriction. Blockade of the muscarinic receptor, however, is known to modify both the exercise-induced asthma and non-specific bronchial reactivity. This would imply that in some patients the vagal reflex may be an important component of bronchoconstriction and that this effect is possibly mediated through the postsynaptic muscarinic receptors.
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